SynthesisThe Lancet. Oncology2022

Aromatase inhibitors versus tamoxifen in premenopausal women with oestrogen receptor-positive early-stage breast cancer treated with ovarian suppression: a patient-level meta-analysis of 7030 women from four randomised trials.

Early Breast Cancer Trialists' Collaborative Group (EBCTCG)PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.